We are live on
!
Find out more
MYOK
MyoKardia, Inc. Common Stock
MYOK
MYOK
Delisted
MYOK was delisted on the 16th of November, 2020.
121 hedge funds and large institutions have $1.26B invested in MyoKardia, Inc. Common Stock in 2017 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 31 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
61% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 31
30% more capital invested
Capital invested by funds: $974M → $1.26B (+$289M)
26% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 23
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
5% more funds holding
Funds holding: 115 → 121 (+6)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $863K
Holders
121
Holders Change
+6
Holders Change %
+5.22%
% of All Funds
2.74%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.23%
New
29
Increased
50
Reduced
31
Closed
23
Calls
–
Puts
$863K
Net Calls
-$863K
Net Calls Change
-$863K
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$21.4M |
| 2 |
BlackRock
New York
|
+$20.1M |
| 3 |
Millennium Management
New York
|
+$18.9M |
| 4 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$18M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$14.3M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$14M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$12.5M |
| 3 |
VMI
VHCP Management II
New York
|
-$11.4M |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$10.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$6.11M |
